French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

Swedish Startup close to the North Pole signs 100 million deal with AstraZeneca

It’s Rare Disease Day 2016: Here are 7 Indications which Biotech is Fighting

UK Start-Up Gets €380k to Understand Cancer with CRISPR


Microbiomics and Nestlé: €1.7Bn for New TransAtlantic Drug Development Program

Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark

Merck relinquishes Rare Disease license to instead focus on Immuno-oncology

AstraZeneca Adds New Antisense Drugs to its Pipeline

Versantis, using liposomes technology to detoxify the body

Will Nestlé lead the promising microbiome industry?